Question 1

What is Kartos Therapeutics?

Accepted Answer

Kartos Therapeutics is a Entity.

Question 2

How often does Kartos Therapeutics appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 7 articles.

Question 3

When was Kartos Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on Apr 20, 2026.

Question 4

When was Kartos Therapeutics last mentioned in news?

Accepted Answer

Last active on Jun 29, 2026.

Question 5

What is Kartos Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 80 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Kartos Therapeutics in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Kartos Therapeutics?

Accepted Answer

Ipsen acquires Kartos Therapeutics (Apr 20, 2026, 7 articles).

Question 8

How did the "Ipsen acquires Kartos Therapeutics" event impact Kartos Therapeutics?

Accepted Answer

Kartos Therapeutics is being acquired by Ipsen for up to $1.75 billion, including an upfront payment and potential milestone payments. Its primary asset, navtemadlin, will be integrated into Ipsen's pipeline.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.